Amgen partnering with Humana to study diseases
Thousand Oaks biotechnology giant Amgen announced a collaboration agreement with Louisville, Ky.-based Humana on Aug. 17 to study conditions like cardiovascular disease, osteoporosis, neurologic disorders, inflammatory diseases and cancer. The two companies currently have six projects underway focusing on improving health care quality and costs with data from Humana’s 13 million members, including wearable technology, Read More →
Leaders tour Ventura County Medical Center’s new North Tower
Business, government and medical leaders on Aug. 14 toured the Ventura County Medical Center’s new North Tower, which is slated to start serving patients on Aug. 20. The group suited up to view state-of-the-art operating rooms and the tower’s new intensive care unit, which brings the number of ICU rooms to 46 between the new Read More →
Stellar Biotechnologies revenues fall in third quarter
Revenues for Port Hueneme-based immunotherapy developer Stellar Biotechnologies fell to $20,000 for its fiscal third quarter, about a ninth what it was for the same quarter the prior year. The slump in sales was a product of lower volume orders for the three months ended June 30, the company said in an earnings release Aug. Read More →
Sientra increases sales but legal settlement doubles losses
Sientra increased net sales more than 30 percent for its second quarter ended June 30 but net losses doubled to $20.4 million, or $1.07 per share. The Goleta breast implant designer and manufacturer brought in $8.2 million in sales, up from $6.2 million for the second quarter of 2016, primarily for its breast products. Its Read More →
Mannkind reports net loss for second quarter
Mannkind reported $2.16 million in revenues Aug. 7, for a net loss of around $35.3 million for its second quarter, and announced the launch of a clinical trial for its inhalable insulin product Afrezza in partnership with One Drop. Revenues came primarily from the Westlake Village biotech company’s product sales, with $615,000 from collaborations and Read More →
Sienna stock still soaring after $65 million IPO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen net income up 11.3 percent for second quarter
Net income at Inogen rose 11.3 percent for the second quarter to $8.3 million, after a 17.5 percent bump in its revenues to $64.1 million. The Goleta-based portable oxygen concentrator maker sold 32,400 units during the quarter ended June 30, up nearly 30 percent from the same period in 2016. Earnings per share rose slightly Read More →
